Recombinant P-selectin glycoprotein-ligand-1 delays thrombin-induced platelet aggregation: A new role for P-selectin in early aggregation

British Journal of Pharmacology

Volumn 148, Issue 3, 2006, Pages 299-305

  Théorêt, Jean François ^a   Chahrour, Wissam ^a   Yacoub, Daniel ^a   Merhi, Yahye ^a  

^a MONTREAL HEART INSTITUTE   (Canada)

Author keywords

Aggregation; GPIIb IIIa; P selectin; Platelets; PSGL 1

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ABCIXIMAB; FIBRINOGEN RECEPTOR ANTAGONIST; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY P8G6; P SELECTIN GLYCOPROTEIN LIGAND 1; PADGEM PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; RECOMBINANT PROTEIN; THROMBIN; UNCLASSIFIED DRUG;

ARTICLE; CELL ISOLATION; CELL KINETICS; CELL STIMULATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; HUMAN; HUMAN CELL; MOLECULAR MECHANICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; THROMBOCYTE AGGREGATION;

BLOOD PLATELETS; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; KINETICS; MEMBRANE GLYCOPROTEINS; P-SELECTIN; PLATELET AGGREGATION; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; RECOMBINANT PROTEINS; THROMBIN;

EID: 33744500467     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/sj.bjp.0706734     Document Type: Article

References (31)

1. BIENVENU, J.G., TANGUAY, J.F., THÉORÊT, J.F., KUMAR, A., SCHAUB, R.G. & MERHI, Y. (2001). Recombinant soluble P-selectin glycoprotein ligand-1-Ig reduces restenosis through inhibition of platelet-neutrophil adhesion after double angioplasty in swine. Circulation, 103, 1128-1134.
2. CARON, A., THÉORÊT, J.F., MOUSA, S.A. & MERHI, Y. (2002). Anti-platelet effects of GPIIb-IIIa and P-selectin antagonism, platelet activation, and binding to neutrophils. J. Cardiovasc. Pharmacol., 40, 296-306.
3. FARADAY, N., SCHARPF, R.B., DODD-O, J.M., MARTINEZ, E.A., ROSENFELD, B.A. & DORMAN, T. (2001). Leukocytes can enhance platelet-mediated aggregation and thromboxane release via interaction of P-selectin glycoprotein ligand 1 with P-selectin. Anesthesiology, 94, 145-151.
4. FRENETTE, P.S., DENIS, C.V., WEISS, L., JURK, K., SUBBARAO, S., KEHREL, B., HARTWIG, J.H., VESTWEBER, D. & WAGNER, D.D. (2000). P-selectin glycoprotein ligand 1 (PSGL-1) is expressed on platelets and can mediate platelet-endothelial interactions in vivo. J. Exp. Med., 191, 1413-1422.
5. GARTNER, T.K., WILLIAMS, D.C., MINION, F.C. & PHILLIPS, D.R. (1978). Thrombin-induced platelet aggregation is mediated by a platelet plasma membrane-bound lectin. Science, 200, 1281-1283.
6. JANG, Y., LINCOFF, A.M., PLOW, E.F. & TOPOL, E.J. (1994). Cell adhesion molecules in coronary artery disease. J. Am. Coll. Cardiol., 24, 1591-1601.
7. KUMAR, A., VILLANI, M.P., PATEL, U.K., KEITH JR, J.C. & SCHAUB, R.G. (1999). Recombinant soluble form of PSGL-1 accelerates thrombolysis and prevents reocclusion in a porcine model. Circulation, 99, 1363-1369.
8. LI, L., QIAN, K.X. & GENG, J.G. (2002). A 28-kDa glycoprotein functions as a platelet ligand for P-selectin (CD62P). Thromb. Haemost., 87, 706-711.
9. MACFARLANE, S.R., SEATTER, M.J., KANKE, T., HUNTER, G.D. & PLEVIN, R. (2001). Proteinase-activated receptors. Pharmacol. Rev., 53, 245-282.
10. MARCUS, A.J. (1994). Thrombosis and inflammation as multicellular processes: significance of cell-cell interactions. Semin. Hematol., 31, 261-269.
11. MARMUR, J.D. & CAVUSOGLU, E. (2002). The use of the glycoprotein IIb/IIIa receptor antagonists during percutaneous coronary intervention. J. Interv. Cardiol., 15, 71-84.
12. MCEVER, R.P. & CUMMINGS, R.D. (1997). Role of PSGL-1 binding to selectin in leukocyte recruitment. J. Clin. Invest., 100 (Suppl 11), S97-S103.
13. MERTEN, M., BEYTHIEN, C., GUTENSOHN, K., KUHNL, P., MEINERTZ, T. & THIAGARAJAN, P. (2005). Sulfatides activate platelets through P-selectin and enhances platelet and platelet-leukocyte aggregation. Arterioscler. Thromb. Vasc. Biol., 25, 258-263.
14. MERTEN, M., CHOW, T., HELLUMS, J.D. & THIAGARAJAN, P. (2000). A new role for P-selectin in shear-induced platelet aggregation. Circulation, 102, 2045-2050.
15. MERTEN, M. & THIAGARAJAN, P. (2000). P-selectin expression on platelet determines size and stability of platelet aggregates. Circulation, 102, 1931-1936.
16. MERTEN, M. & THIAGARAJAN, P. (2001). Role for sulfatides in platelet aggregation. Circulation, 104, 2955-2960.
17. MICKELSON, J.K., LAKKIS, N.M., VILLARREAL-LEVY, G., HUGHES, B.J. & SMITH, C.W. (1996). Leukocyte activation with platelet adhesion after coronary angioplasty: a mechanism for recurrent disease? J. Am. Coll. Cardiol., 28, 345-353.
18. MYERS JR, D.D., SCHAUB, R., WROBLESKI, S.K., LONDY III, F.J., FEX, B.A., CHAPMAN, A.M., GREENFIELD, L.J. & WAKEFIELD, T.W. (2001). P-selectin antagonism causes dose-dependent venous thrombosis inhibition. Thromb. Haemost., 85, 423-429.
19. NASH, G.B. (1994). Adhesion between neutrophils and platelets: a modulator of thrombotic and inflammatory events? Thromb. Res., 74 (Suppl 1), S3-S11.
20. NEUMANN, F.J., OTT, I., GAWAZ, M., PUCHNER, G. & SCHOMIG, A. (1996). Neutrophil and platelet activation at balloon-injured coronary artery plaque in patients undergoing angioplasty. J. Am. Coll. Cardiol., 27, 819-824.
21. OTT, I., NEUMANN, F.J., GAWAZ, M., SCHMITT, M. & SCHOMIG, A. (1996). Increased neutrophil-platelet adhesion in patients with unstable angina. Circulation, 94, 1239-1246.
22. 3) inhibitors. Blood, 92, 3240-3249.
23. ROMO, G.M., DONG, J.F., SCHADE, A.J., GARDINER, E.E., KANSAS, G.S., LI, C.Q., MCINTIRE, L.V., BERNDT, M.C. & LOPEZ, J.A. (1999). The glycoprotein Ib-IX-V complex is a platelet counter-receptor for P-selectin. J. Exp. Med., 190, 803-814.
24. SECOND SYMPHONY INVESTIGATORS (2001). Randomized trial of aspirin, sibrafiban or both for secondary prevention after acute coronary syndromes. Circulation, 103, 1727-1733.
25. SERRANO JR, C.V., RAMIRES, J.A., VENTURINELLI, M., ARIE, S., D'AMICO, E., ZWEIR, J.L., PILEGGI, F. & DA LUZ, P.L. (1997). Coronary angioplasty results in leukocyte and platelet activation with adhesion molecule expression. Evidence of inflammatory responses in coronary angioplasty. J. Am. Coll. Cardiol., 29, 1276-1283.
26. TANGUAY, J.F., GEOFFROY, P., SIROIS, M.G., LIBERSAN, D., KUMAR, A., SCHAUB, R.G. & MERHI, Y. (2004). Prevention of in-stent restenosis via reduction of thrombo-inflammatory reactions with recombinant P-selectin glycoprotein ligand-1. Thromb. Haemost., 91, 1186-1193.
27. TCHENG, J.E., ELLIS, S.G., GEORGE, B.S., KEREIAKES, D.J., KLEIMAN, N.S., TALLEY, J.D., WANG, A.L., WEISMAN, H.F., CALIFF, R.M. & TOPOL, E.J. (1994). Pharmacodynamics of chimeric glycoprotein IIb/IIIa integrin antiplatelet antibody Fab 7E3 in high-risk coronary angioplasty. Circulation, 90, 1757-1764.
28. THÉORÊT, J.F., BIENVENU, J.G., KUMAR, A. & MERHI, Y. (2001). P-selectin antagonism with recombinant P-selectin glycoprotein ligand-1 (rPSGL-Ig) inhibits circulating activated platelet binding to neutrophils induced by damaged arterial surfaces. J. Pharmacol. Exp. Ther., 298, 658-664.
29. WANG, K., ZHOU, X., ZHOU, Z., TARAKJI, K., QIN, J.X., SITGES, M., SHIOTA, T., FORUDI, F., SCHAUB, R.G., KUMAR, A., PENN, M.S., TOPOL, E.J. & LINCOFF, A.M. (2002). Recombinant soluble P-selectin glycoprotein ligand-Ig (rPSGL-Ig) attenuates infarct size and myeloperoxidase activity in a canine model of ischemia - reperfusion. Thromb. Haemost., 88, 149-154.
30. WANG, K., ZHOU, Z., ZHOU, X., TARAKJI, K., TOPOL, E.J. & LINCOFF, A.M. (2001). Prevention of intimal hyperplasia with recombinant soluble P-selectin glycoprotein ligand-immunoglobulin in the porcine coronary artery balloon injury model. J. Am. Coll. Cardiol., 38, 577-582.
31. YANG, J., FURIE, B.C. & FURIE, B. (1999). The biology of P-selectin glycoprotein ligand-1: its role as a selectin counterreceptor in leukocyte-endothelial and leukocyte platelet interaction. Thromb. Haemost., 81, 1-7.